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Abstract Preselected cyanobacterial strains (available from
culture collections and our own isolates), belonging
primarily to the heterocystous cluster, were screened for
inhibitors against butyrylcholinesterase. About one-half of
the extracts exhibited inhibitory activity. Nostocarboline,
the responsible metabolite in Nostoc 78–12A, was studied
in more detail as an acetylcholinesterase (AChE) inhibitor.
The compound showed potent activity against this enzyme
(IC50 = 5.3 µM), and the Michaelis-Menten kinetics
indicated a non-competitive component in the inhibitory
mechanism. In addition, nostocarboline turned out to be a
potent inhibitor of trypsin (IC50 = 2.8 µM), and thus is the
first described cyanobacterial serine protease inhibitor of an
alkaloid structure. The function of nostocarboline in aquatic
ecosystems and its potential as a lead compound for the
development of useful therapeutic AChE inhibitors is
discussed.
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Introduction
Many secondary metabolites isolated from cyanobacteria
show bioactivities and may serve as defensive agents (Burja
et al. 2001). By producing such agents, microorganisms
minimise the risk of being damaged, out-competed or killed
by microorganisms, viruses, inter- and intra-specific com-
petitors and herbivores.
Bioactive cyanobacterial secondary metabolites belong
to different chemical classes, such as peptides, lipids,
alkaloids and others (Metcalf and Codd 2004; Haider et
al. 2003). Among the cyanobacterial alkaloids, some
compounds are extremely potent neurotoxins (anatoxins,
saxitoxins) exhibiting different modes of action (Carmichael
1992; Metcalf and Codd 2004). One neurophysiological
target site is the acetylcholinesterase (AChE) that controls
acetylcholine (ACh) concentrations in synaptic clefts by
hydrolysing the neurotransmitter ACh into acetate and
choline. Potent inhibitory activity was found for anatoxin-
a(s), an irreversible inhibitor of AChE, produced by a
strain of Anabaena (Mahmood and Carmichael 1987). As
a consequence of the inhibited hydrolysis of ACh, the
excess of neurotransmitter causes maintenance of the
depolarisation of the postsynaptic membrane. Symptoms
of intoxication in mammals include, amongst others,
hypersalivation [suffix (s) in anatoxin-a(s)=salivation],
tremors and death. To our knowledge, no other cyanobac-
terial metabolite has been described as an inhibitor of
AChE.
We undertook a screening for cyanobacterial cholines-
terase inhibitors with strains that had shown at least slight
grazer toxicity (Todorova et al. 1995; Becher and Jüttner
2006). This screening had led to the isolation and structural
determination of the alkaloid nostocarboline from the
cyanobacterium Nostoc 78–12A (Becher et al. 2005). In
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that previous publication we also described the potent
inhibitory activity of nostocarboline on serum butyrylcho-
linesterase (BChE) and discussed the potential importance
of (acetyl)cholinesterase inhibitory β-carbolines for the
pathology of Parkinson’s disease (PD) and the prospective
value of these compounds for the therapy of Alzheimer’s
disease (AD). We now specify the inhibitory activity of
nostocarboline on the key neurophysiological enzyme
AChE. As another new feature we also demonstrate the
potent serine protease inhibitory activity of this compound.
The potential medical applications and the ecological
function of nostocarboline as a defensive compound are
discussed.
Materials and methods
Cultures (Table 1) were grown under sterile conditions in
300-mL Erlenmeyer flasks as described previously (Becher
and Jüttner 2005). Cultures used for experiments were about
6 weeks old when harvested. Cyanobacterial biomass was
harvested by centrifugation or by the use of a sieve (polyester,
21 µm mesh width; Sefar, Rüschlikon, Switzerland).
Enzyme inhibition assays
Cholinesterase inhibitory activities were studied for BChE
(from horse serum; Sigma, St. Louis, MO) and AChE (from
the electric eel, Sigma). Cholinesterase inhibitory and
activating effects of cyanobacterial extracts and compounds
were determined with a colorimetric procedure based on the
Ellman reaction (Ellman et al. 1961). The extraction of
cyanobacteria was performed with 60% (v/v) MeOH/H2O.
The extracts were dried on a rotary evaporator; the residues
obtained were dissolved in Sørensen phosphate buffer
(67 mM; pH 7.2). The Sørensen buffer was also used for
dissolving the enzymes, substrates and inhibitors. For each
assay, an extract equivalent to 65 mg wet cyanobacterial
biomass was dissolved in 160 µL Sørensen buffer. When
the solution was turbid or contained particles, the suspen-
sion was filtered through a 0.45-µm syringe filter (nylon;
Semadeni, Ostermundingen, Switzerland) to avoid light
scattering in the subsequently performed colorimetric assays.
To test inhibitory activity on BChE, a mixture of the
substrate butyrylthiocholine iodide (5 mM), the indicator
reagent 5,5’-dithio-bis-2-nitrobenzoate (DTNB, 0.25 mM)
and buffer (pH 7.2) [Sigma Diagnostics Cholinesterase
(BTC) reagent, no longer available (2006)] was used. For
each assay, 60 µL of this reagent, 30 µl BChE (1–15 mU)
and 160 µl dissolved extract or inhibitors were added to
350-µl microwells of a transparent 96-well polystyrene
plate (Corning Inc., Corning, New York). The synthetic di
(hydromethyl)dihydroxypyrrolidine (DMDP) tested for
BChE inhibition was obtained from Sigma.
For detailed testing of the AChE inhibitory activity of
nostocarboline, acetylthiocholine iodide (ATC, 5 mM;
Fluka, Buchs, Switzerland) was used as the substrate. To
study the inhibition kinetics, different concentrations of the
substrate (S) were applied (0.03–0.6 mM ATC) in the
presence of different inhibitor concentrations. DTNB
Table 1 Designation and origin of the investigated cyanobacteria
Cyanobacterial strain assayed Culture statea Identification number in a culture collection; designation
of identical strainb
Origin of the strainb
Cylindrospermum sp. ax ATCC 29412 ATCC
Fischerella sp. (43239) ax ATCC 43239 ATCC
Nostoc sp. (78–12A) ax ATCC 43238; Anabaena sp. (78–12A) MSU
Nostoc sp. (31) ax ATCC 43529 MSU
Fischerella sp. (1829) ax UTEX 1829 MSU
Aphanothece sp. m Taiwan
JU 5 (LPP group) m Türler See
Calothrix anomala m SAG 1410–4 SAG
Calothrix thermalis m SAG 37.79 SAG
Calothrix sp. (7507) ax PCC 7507 PCC
Fischerella cf. major m EAWAG 108a Spiez
a Axenic (ax) or monoxenic (m)
bATCC American Type Culture Collection, Rockville, MD; UTEX Culture collection, University of Texas, Austin, TX; SAG Sammlung von
Algenkulturen, Göttingen, Germany; PCC Pasteur Culture Collection, Paris, France; EAWAG Eidgenössische Anstalt für Wasserversorgung,
Abwasserreinigung und Gewässerschutz, Dübendorf, Switzerland; MSU Cultures were obtained from C.P. Wolk, Michigan State University, East
Lansing, Michigan USA; Taiwan cyanobacterium from Taiwan (Jüttner and Wu 2000) were collected and isolated by F. Jüttner; Türler See JU 5
was collected and isolated by F. Jüttner from a biofilm that developed in the littoral zone of Türler See, Switzerland; Spiez Culture was obtained
from C. Beuret, Spiez Laboratory, Switzerland
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(Fluka) was applied in the same concentration as in the
BChE assay (0.25 mM). For each assay with AChE, 60 µL
ATC, 60 µL DTNB, 30 µL AChE (ca. 1.5 mU) and 100 µL
dissolved synthetic nostocarboline (Becher et al. 2005), or
buffer in the case of controls, were added to a microwell of
a 96-well polystyrene plate.
Colorimetricmeasurements (at 405 nm) were performed on
a SpectraMax 190 multichannel spectrophotometer (Spectra-
Max, Molecular Devices, Sunnyvale, CA) at 30 °C. Three
replicates were measured for each inhibitor of the extract or
pure compound and the substrate concentration. The reaction
velocity (v) was calculated from the slope of the initial
velocity (mean of three replicates). Inhibition and activation
were determined in relation to 100% activity controls.
Analyses of the inhibitory activity on trypsin of synthetic
nostocarboline were performed with a fluorometric enzyme
assay (Baumann et al. 2007). The fluorescent enzyme
substrate (Kawabata et al. 1988) was measured on a
fluorescence plate reader (SpectraMax Gemini XS, Molec-
ular Devices) in black polystyrene 96-well microtitre plates
(Corning). For trypsin inhibition experiments, dimethyled
trypsin from porcine pancreas (proteomics grade, Sigma
T6567) was used; 5 µL trypsin (67 mU), 145 µL Tris/HCl
buffer (50 mM Tris/HCl, 150 mM NaCl, 1 mM CaCl2,
0.1 mg·mL−1 bovine serum albumin, pH 8.0) and 30 µl
inhibitor solution (in ten different concentrations in the
range of 12.5 nM–47 µM final concentration in 200 µL)
were preincubated for 5 min at 37 °C. To start the reaction,
20 µL substrate solution [50 µM Boc-Gln-Ala-Arg-7-
amido-4-methylcoumarin (Bachem, Bubendorf, Switzer-
land) in Tris/HCl buffer] were added, and the fluorescence
change (λex380 nm, λem440 nm) was monitored for 20 min
at 37 °C. Different amounts of nostocarboline were tested
in three replicates, and determination of inhibitory activity
was similar to that described for cholinesterase.
Toxicity assay
Acute toxicity assays with Thamnocephalus platyurus were
carried out for 1, 10, 25, 50 and 100 μM nostocarboline
solutions as described by Blom et al. (2003). The same
molarities were also tested on 10–14 chironomid larvae that
were collected from the littoral zone of Lake Zürich,
Switzerland.
Results
Screening of cyanobacterial extracts for BChE inhibitory
activity
Moderate inhibitory effects were found for extracts of the
cyanobacteria JU 5, Fischerella (43239) and Fischerella cf.
major (Table 2). Because Fischerella (43239) is a producer
of hapalindoles exhibiting acute insecticidal toxicity
(Becher et al. 2007), we tested the hapalindole-containing
C18 HPLC fraction for inhibitory activity on BChE. No
inhibition was found for this fraction isolated from an
extract of 100 mg wet biomass. The fraction was tested
both as an aqueous (the equivalent of 100 mg wet biomass/
250 µL test volume) and a (4% v/v) methanolic solution
(the equivalent of 100 mg wet biomass was dissolved in
10 µL methanol/250 µL test volume). Low inhibitory
effects on BChE activity were observed for extracts from
Nostoc (31) and Calothrix anomala. Extracts of Calothrix
thermalis and Fischerella (1829) did not show any
inhibitory effects. Calothrix (7507) and Aphanothece sp.
showed increased activities of BChE compared to the 100%
controls. Cylindrospermum sp. exhibited the highest inhib-
itory activities against BChE. However, when DMDP
(1 mM), an effective digestive glucosidase inhibitor isolated
from this strain of Cylindrospermum sp. (Jüttner and
Wessel 2003), was studied, no inhibitory effect on BChE
was found. Another strain with high inhibitory activities
was Nostoc (78–12A) (Fig. 1). This activity could be
attributed to the alkaloid nostocarboline (Becher et al.
2005).
Inhibitory activity of nostocarboline to AChE
The synthesized compound nostocarboline iodide (Fig. 2)
was used to determine the inhibition of AChE in more
detail. The AChE was from electric eel and its Michaelis
constant was calculated to be Km = 0.07–0.11 mM. This
was consistent with the values of 0.11–0.22 mM reported
by Mahmood and Carmichael (1987). Nostocarboline
exhibited a concentration-dependent inhibitory activity
against AChE (Fig. 3a). The concentration of nostocarbo-
Table 2 Modulation of butyrylcholinesterase (BChE) activities by
crude extracts of different cyanobacterial strains. The activation and
inhibition are calculated from the initial velocities (0–15 min)
Cyanobacterial strain Activation (%) Inhibition (%)
Control without extract 0 0
JU 5 (LPP group) 0 68
Cylindrospermum sp. 0 89
Nostoc (78–12A) 0 85
Nostoc (31) 0 18
Fischerella cf. major 0 47
Fischerella (43239) 0 41
Fischerella (1829) 0 0
Calothrix anomala 0 24
Calothrix thermalis 0 0
Calothrix (7507) 47 0
Aphanothece sp. 12 0
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line required to obtain half-maximal inhibition of AChE
was IC50 = 5.3 μM (SE ± 0.7). To study the inhibition
kinetics of nostocarboline for AChE, the initial enzyme
rates (v) were assayed with a series of substrate concen-
trations in the presence of different inhibitor concentrations.
The Michaelis-Menten plot (Fig. 3b) showed hyperbolic
curves with decreasing maximal velocities (vmax) at
increasing concentrations of nostocarboline. The double
reciprocal Lineweaver-Burk plot (Fig. 3c) showed an inter-
ception point of the regression lines left of the [1/vmax] axis
and close to the [1/S] axis, while a slightly negative [S/vmax]
value of the interception point of the regression lines can be
seen in the Hanes plot (Fig. 3d).
Inhibitory activity of nostocarboline on trypsin
When nostocarboline was tested as an inhibitor against
porcine pancreas trypsin, strong inhibitory effects were
observed. From the regression curve for the concentration
dependent inhibition (Fig. 4), an IC50 value of 2.8 μM
(SE ± 0.2) was calculated.
Toxicity assay
Moderate toxic effects were found for synthetic nostocarbo-
line when it was tested on the crustacean Thamnocephalus
platyurus. Mortality was 13–20% at 0–10 μM, 27% at
25 μM, 33% at 50 μM and 100% at 100 μM nostocarboline
after 24-h testing of 30 animals per molarity. No mortality
was found when nostocarboline was tested at a 50 μM
concentration on chironomids collected from biofilms of
the littoral zone of Lake Zürich, and only two out of ten
larvae died at 100 μM concentration.
Discussion
We tested 11 axenic and monoxenic cyanobacterial strains
in our culture collection for their inhibitory activity against
BChE. Seven of the crude extracts exhibited at least some
inhibitory activity. Because bioactive compounds have been
described before from some of these strains, the available
compounds were also tested for BChE inhibitory activity.
Only nostocarboline showed inhibitory activity to BChE
(Becher et al. 2005), while the other bioactive compounds
were negative. The high inhibitory activity of nostocarbo-
line prompted us to study the inhibitory properties of this
compound in more detail.
Although most known cholinesterase inhibitors act
against both BChE and AChE, some inhibitors have been
found to be selective for only one of these two enzymes
(Taylor 1991). When nostocarboline was tested as an
inhibitor for AChE (IC50 = 5.3 µM) its activity was even
stronger than that for serum BChE (IC50 = 13.2 μM). The
slightly positive 1/vmax value of the interception point of
the regression lines in the Lineweaver-Burk diagram and
the slightly negative S/vmax value of the interception point
of the regression lines in the Hanes plot indicate a non-
competitive inhibition with a negative influence on the
substrate by nostocarboline (and vice versa) when binding
to the enzyme (mixed-inhibition, Bisswanger 2000).
Nostocarboline belongs to the chemical class of the β-
carbolines, which are frequently found to be potent
bioactive compounds. β-Carbolines affect the endocrine-
and nervous system and modulate the functionality of
adrenalin, dopamine and serotonin via inhibition of mono-
amine oxidase. In addition, β-carbolines from plants are
believed to cause hallucinations by binding to serotonin
receptors (reviewed by Robinson et al. 2003).
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measure of absorbance) by three selected cyanobacterial crude extracts
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Carbolinium ions have been found in the human brain
and have been discussed as endogenous causative factors of
PD (Matsubara et al. 1993). Kuhn et al. (1996) suggested
that β-carbolines such as harmane and norharmane might
be neurotoxins causing PD. Gearhart et al. (2002) found β-
carboline 2N-methyltransferase activity in the mammalian
brain. This enzyme converts β-carbolines, like harmane and
norharmane, into 2N-methylated β-carbolinium cations,
which are analogues of the PD-inducing toxin 1-methyl-4-
pyridinium cation (MPP+). A β-carbolinium cation that
shares the toxic properties of MPP+ is the quarternary
deschloro-nostocarboline, 2-methylnorharmane, which has
been isolated from post-mortem brain tissue (Matsubara
et al. 1993).
We have described a similar IC50 value for 2-methylno-
rharmane on BChE (Becher et al. 2005) as that reported on
AChE (Ghosal et al. 1972). Subsequently, Schott et al.
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Fig. 3 a Concentration-dependent nonlinear regression of the inhibi-
tion of acetylcholinesterase (AChE) by nostocarboline iodide (mean of
three replicates, R2=0.99). b–d In vitro maximal enzyme activity, vmax
(Δ absorbance/s) of AChE (0.0015 U) with increasing concentrations
of substrate S (acetylthiocholine iodide, mM) and with 10 μM (▪),
20 μM (▴) and without (♦) nostocarboline iodide. The illustration
shows the Michaelis-Menten plot (b), the Lineweaver-Burk plot (c)
and the Hanes plot (d). R2 for the different linear and nonlinear
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(2006) tested additional β-carbolines and confirmed our
finding of the inhibitory potency for quarternary β-carbo-
lines in the same concentration range as for galanthamine,
an approved drug for treatment of AD. Interestingly, tertiary
carbolines such as the brunneins are much less active as
cholinesterase inhibitors (Teichert et al. 2007).
The cholinergic hypothesis (Bartus et al. 1982) states
that a degeneration of cholinergic neurons and the
associated loss of cholinergic neurotransmission leads to a
decline in cognitive function as a symptom of AD. Some
AChE inhibitors, such as galanthamine, donepezil and
rivastigmine, are used as pharmaceuticals to alleviate the
symptoms of AD by impeding the hydrolysis of ACh.
Pharmaceutical control of AChE with inhibitors seems even
more reasonable as the enzyme is also involved in the
formation of amyloid beta peptide (Inestrosa et al. 1996;
Selkoe 1999). Recently, Hostettmann et al. (2006) reviewed
natural inhibitors of AChE and emphasised the importance
of screening programs to find additional lead compounds
for the treatment of AD. Cholinesterase inhibitors are also
of significance for the treatment of several other diseases,
such as myasthenia gravis (grave muscle weakness). A
summary of the use of cholinesterase inhibitors in anaes-
thesia, intensive care medicine, emergency medicine and
pain therapy is given by Kleinschmidt et al. (2005).
Schott and co-workers (2006) suggested tertiary β-carbo-
lines as potential prodrugs that could be bioactivated by
methylation for the treatment of AD. Our assay indicated a
non-competitive component in the inhibition of AChE by
nostocarboline. Bartolini et al. (2003) found that non-
competitive AChE inhibitors like donepezil hinder amyloid
beta protein aggregation. In view of the comparable
inhibitory activity of nostocarboline (and other β-carbolines)
to galanthamine (which is characterised as a competitive in-
hibitor, see Scott and Goa 2000), these compounds should be
considered in the design of new drugs for the therapy of AD.
As the reaction centre of AChE is considered to
resemble the catalytic triade of chymotrypsin and other
serine proteases (Sussman and Silman 1992), we assumed
that nostocarboline might also be an inhibitor of proteases.
A similar inhibitory activity on AChE and serine proteases
is known for phenylmethylsulfonyl fluoride and other
sulfonyl fluorides (Fahrney and Gold 1963; Kraut et al.
2000). We found nostocarboline to be a strong inhibitor of
mammalian trypsin. The IC50 inhibition value was in the
range of serine protease inhibitors from cyanobacteria that
belong to the chemical group of cyclic peptides (Baumann
et al. 2007), depsipeptides and linear peptides with unusual
amino acids (Welker and von Döhren 2006). So far all
serine protease inhibitors that have been isolated from
cyanobacteria are peptides; nostocarboline is the first
example of an alkaloid produced by cyanobacteria showing
serine protease inhibition. The interference of nostocarbo-
line in protein metabolism may also be of primary
pharmaceutical importance because serine proteases are
implicated in processing of the amyloid precursor protein
(Grau et al. 2005; Park et al. 2006).
The multifunctional character of nostocarboline might be
advantageous for Nostoc (78–12A) in resisting attacking
organisms. An obvious biological function of cyanobacte-
rial secondary compounds is chemical defence or deter-
rence against grazers (Carmichael 1992; Codd 1995; Wylie
and Paul 1988). Several Nostoc strains are resistant to
predation. This is probably related to the production of
large amounts of sheath material and synthesis of toxins.
Many secondary metabolites, including the β-carboline
norharmane (Volk 2005, 2007; Volk and Furkert 2006),
have already been isolated from Nostoc species (reviewed
by Dembitsky and Řezanka 2005; Volk and Mundt 2007).
We expected potent neurotoxicity of the AChE inhibitor
producing Nostoc sp. (78–12A), but only moderate toxic
effects were found for nostocarboline when tested on the
crustacean Thamnocephalus platyurus. No clear toxic
effects were found when nostocarboline was tested on
chironomids sampled from biofilms of the littoral zone of
Lake Zürich, nor when fresh biomass of Nostoc sp. (78–
12A) was fed for 8 days to larvae of Chironomus riparius
from a laboratory culture (Becher and Jüttner 2006). The
reason for these low effects on chironomids might be due to
adaptation and resistance of the grazers. The AChE for the
enzyme assay was isolated from a vertebrate (electric eel)
and thus possibly differed from the insect AChE from C.
riparius (for differences between AChE of Torpedo
californica and Drosophila melanogaster, see Harel et al.
2000). Resistance mechanisms against insecticides, such as
organophosphates and carbamates, are well known for pests
and can arise e.g. through enhanced detoxification by
cytochrome or structural modification of the target enzyme
AChE (Horowitz and Denholm 2001). The induction of
cytochrome P450-dependent monooxygenases by sublethal
concentrations of pesticides was also shown for C. riparius
and C. tentans (Sturm and Hansen 1999; Miota et al. 2000).
To be relevant in an ecological context, the effects of a
compound must not be lethal. We suppose it possible that
the physiological response to nostocarboline only affects
parts of the grazer, e.g. the mouthparts. Such an effect
might be a deterrent to the grazer and thus protective for the
cyanobacterium. Further experiments, such as toxicity
testing against other aquatic or terrestrial animals, as well
as in vitro testing of nostocarboline on AChE of Chirono-
mus and additional test organisms may provide further
information about the ecological and neurotoxicological
significance of the compound.
The trypsin inhibition property of nostocarboline likely
is an additional defence mechanism against grazers.
Trypsin-like proteases are major components of the
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digestive proteases in the guts of invertebrates. Any
inhibition of this enzyme leads to starvation of the grazers
and hence to reduced grazing pressure. The importance of
this effect is in line with the occurrence of peptidic trypsin
inhibitors in all inedible cyanobacteria.
Furthermore, the protease inhibitory activity might be
directed against photosynthetic organisms competing for
light. As (serine) proteases are present in chloroplasts and
e.g. involved in processing of the polypeptide D1 in the
reaction center of photosystem II (Nair and Ramaswamy
2004; Trost et al. 1997; Liao et al. 2000), the protease
inhibitory effect might be involved in the described
algicidal activity of nostocarboline (Blom et al. 2006).
The presented activities of the cyanobacterial β-carbo-
line nostocarboline and its potential pharmaceutical and
ecological qualities reveal Nostoc sp. (78–12A) and other
cyanobacteria to be promising sources of lead compounds
for the development of new drugs and pesticides/insecti-
cides (as reviewed for other natural acetylcholineesterase
inhibitors, Houghton et al. 2006) or novel antifouling
agents (reviewed in Gademann 2007).
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